Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.

Abstract

Epstein-Barr virus (EBV)-related haemophagocytic lymphohistiocytosis (EBVr-HLH) has a better prognosis when the virus is rapidly cleared, but the best antiviral approach is controversial. We present a patient to whom the therapeutic standard rituximab was co-administered with valacyclovir and an HLH-specific treatment with favourable viral and clinical… (More)
DOI: 10.1136/bcr-2016-216488

Topics

Cite this paper

@article{Stefanou2016CombiningAA, title={Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.}, author={Christos Stefanou and Christiana Tzortzi and Fotini Georgiou and Chrystalla Timiliotou}, journal={BMJ case reports}, year={2016}, volume={2016} }